Robert A. Settineri;Gonzalo Ferreira de Mattos;Garth L. Nicolson;Paul C. Breeding
发明人:
Garth L. Nicolson,Robert A. Settineri,Gonzalo Ferreira de Mattos,Paul C. Breeding
申请号:
US16870868
公开号:
US20200268775A1
申请日:
2020.05.08
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A method of oral delivery of phospholipid/inulin compositions comprising capsules, tablets, chewable wafers or powdered material in a liquid carrier in quantities effective for treating pain from overactive neurons. The phospholipid/inulin compositions were also shown to be effective in reducing depression and intestinal malfunctions including, but not limited to, diarrhea and constipation, and improving sleep pattern. The compositions further including effective amounts of caffeine also reduces fatigue and enhances alertness and focus.